Scientific Advisory Board
Comprised of internationally recognized experts in oncology research and drug development, our Scientific Advisory Board supports the advancement of our differentiated ADC pipeline through strategic and scientific counsel.
Dr. Anthony Tolcher, M.D., FRCPC, FACP
Read more
Dr. John Lambert, Ph.D.
Read more
Dr. Kapil Dhingra, M.D
Read more
Prof. Paul W.H.I Parren, Ph.D.
Read more
Who We Are
Grounded in more than 20 years of ADC expertise, Byondis is evolving the field with novel payload platforms, advanced masking technology, and optimized linker and conjugation strategies.
Leadership Team
Our leadership team has broad scientific, clinical, operational and partnering experience and is well networked within the pharmaceutical industry.
